Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.510
-0.050 (-1.95%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,286,583
Market Cap
23.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| NeuroSense Therapeutics | 17 |
| Barinthus Biotherapeutics | 14 |
| Neuphoria Therapeutics | 8 |
TVRD News
- 17 days ago - Tvardi Therapeutics upgraded to Overweight at Piper after Phase 1 data - TheFly
- 17 days ago - Tvardi Therapeutics upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 17 days ago - Why Is Penny Stock Tvardi Therapeutics (TVRD) Up Today? - TipRanks
- 18 days ago - Tvardi Therapeutics upgraded to Outperform from Market Perform at Raymond James - TheFly
- 19 days ago - Tvardi Therapeutics announces positive Phase 1 results for TTI-109 - TheFly
- 19 days ago - Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement - GlobeNewsWire
- 6 weeks ago - Tvardi Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 2 months ago - Tvardi Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire